Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hippocampus | 9 | 2017 | 915 | 1.850 |
Why?
|
| Fragile X Syndrome | 3 | 2017 | 150 | 1.480 |
Why?
|
| rac1 GTP-Binding Protein | 5 | 2017 | 107 | 1.270 |
Why?
|
| rac GTP-Binding Proteins | 3 | 2011 | 39 | 0.980 |
Why?
|
| Actins | 2 | 2017 | 608 | 0.910 |
Why?
|
| Fear | 4 | 2017 | 254 | 0.820 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2009 | 259 | 0.770 |
Why?
|
| Synapses | 3 | 2011 | 509 | 0.700 |
Why?
|
| Cell Membrane | 2 | 2017 | 850 | 0.680 |
Why?
|
| Long-Term Potentiation | 4 | 2017 | 176 | 0.580 |
Why?
|
| Learning | 2 | 2017 | 403 | 0.550 |
Why?
|
| Cognitive Dysfunction | 1 | 2017 | 333 | 0.420 |
Why?
|
| Herpesvirus 6, Human | 2 | 2003 | 81 | 0.410 |
Why?
|
| Neuronal Plasticity | 2 | 2011 | 304 | 0.410 |
Why?
|
| Dendritic Spines | 1 | 2011 | 59 | 0.390 |
Why?
|
| Fragile X Mental Retardation Protein | 3 | 2017 | 126 | 0.380 |
Why?
|
| Multiple Sclerosis | 3 | 2003 | 349 | 0.380 |
Why?
|
| Neuropeptides | 1 | 2011 | 154 | 0.370 |
Why?
|
| Dizocilpine Maleate | 1 | 2009 | 21 | 0.360 |
Why?
|
| Memory | 4 | 2017 | 429 | 0.360 |
Why?
|
| Dendrites | 1 | 2011 | 196 | 0.350 |
Why?
|
| Aminoquinolines | 3 | 2017 | 46 | 0.350 |
Why?
|
| Cognition | 1 | 2015 | 968 | 0.330 |
Why?
|
| Theta Rhythm | 2 | 2017 | 29 | 0.310 |
Why?
|
| Mental Disorders | 1 | 2015 | 862 | 0.300 |
Why?
|
| Association Learning | 1 | 2007 | 28 | 0.300 |
Why?
|
| Synaptic Membranes | 1 | 2006 | 16 | 0.290 |
Why?
|
| Avoidance Learning | 1 | 2007 | 94 | 0.290 |
Why?
|
| Cell Fractionation | 1 | 2006 | 68 | 0.290 |
Why?
|
| Synaptosomes | 1 | 2006 | 37 | 0.280 |
Why?
|
| Myelin Basic Protein | 2 | 2003 | 85 | 0.280 |
Why?
|
| N-Methylaspartate | 1 | 2006 | 50 | 0.280 |
Why?
|
| Brain | 4 | 2015 | 4113 | 0.250 |
Why?
|
| NADPH Oxidases | 1 | 2005 | 146 | 0.250 |
Why?
|
| Protein Transport | 1 | 2006 | 734 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 6 | 2011 | 6942 | 0.230 |
Why?
|
| Roseolovirus Infections | 1 | 2003 | 39 | 0.220 |
Why?
|
| Cytosol | 2 | 2017 | 238 | 0.210 |
Why?
|
| Disease Models, Animal | 3 | 2011 | 7222 | 0.190 |
Why?
|
| Animals | 12 | 2017 | 59536 | 0.180 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2011 | 245 | 0.180 |
Why?
|
| DNA, Viral | 1 | 2002 | 694 | 0.180 |
Why?
|
| Viral Proteins | 1 | 2002 | 435 | 0.170 |
Why?
|
| Antibodies, Viral | 2 | 2003 | 1320 | 0.170 |
Why?
|
| Mice, Knockout | 3 | 2017 | 5710 | 0.160 |
Why?
|
| Prepulse Inhibition | 1 | 2017 | 5 | 0.160 |
Why?
|
| Reflex, Acoustic | 1 | 2017 | 7 | 0.160 |
Why?
|
| Analysis of Variance | 4 | 2011 | 2307 | 0.160 |
Why?
|
| In Vitro Techniques | 3 | 2011 | 1618 | 0.160 |
Why?
|
| Reflex, Startle | 1 | 2017 | 65 | 0.150 |
Why?
|
| p21-Activated Kinases | 1 | 2017 | 122 | 0.150 |
Why?
|
| Pyrimidines | 3 | 2017 | 3518 | 0.150 |
Why?
|
| Mice | 8 | 2011 | 34495 | 0.130 |
Why?
|
| T-Lymphocytes | 3 | 2003 | 3869 | 0.130 |
Why?
|
| Neurons | 3 | 2011 | 2287 | 0.130 |
Why?
|
| Neurogenesis | 1 | 2015 | 238 | 0.110 |
Why?
|
| Silver Staining | 1 | 2011 | 14 | 0.100 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 2011 | 24 | 0.100 |
Why?
|
| Pyrones | 1 | 2011 | 10 | 0.100 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2011 | 43 | 0.100 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2011 | 151 | 0.090 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 388 | 0.090 |
Why?
|
| Electric Stimulation | 1 | 2011 | 426 | 0.090 |
Why?
|
| Raptors | 1 | 2008 | 5 | 0.090 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2008 | 22 | 0.090 |
Why?
|
| Behavior, Animal | 2 | 2009 | 709 | 0.080 |
Why?
|
| Pain | 1 | 2017 | 1658 | 0.080 |
Why?
|
| Schizophrenic Psychology | 1 | 2009 | 102 | 0.080 |
Why?
|
| Exercise Test | 1 | 2010 | 312 | 0.080 |
Why?
|
| Time Factors | 3 | 2011 | 12926 | 0.080 |
Why?
|
| Quinolines | 1 | 2011 | 383 | 0.080 |
Why?
|
| Male | 9 | 2017 | 123000 | 0.080 |
Why?
|
| Centrifugation | 1 | 2006 | 66 | 0.070 |
Why?
|
| Environment | 1 | 2007 | 190 | 0.070 |
Why?
|
| Schizophrenia | 1 | 2009 | 369 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 252 | 0.070 |
Why?
|
| Protein Biosynthesis | 1 | 2009 | 889 | 0.070 |
Why?
|
| Phorbol Esters | 1 | 2005 | 39 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2009 | 1338 | 0.070 |
Why?
|
| Subcellular Fractions | 1 | 2005 | 201 | 0.060 |
Why?
|
| Superoxides | 1 | 2005 | 211 | 0.060 |
Why?
|
| Organ Culture Techniques | 1 | 2005 | 241 | 0.060 |
Why?
|
| Protein Kinases | 1 | 2008 | 874 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2006 | 875 | 0.060 |
Why?
|
| Biological Transport | 1 | 2005 | 597 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2010 | 1129 | 0.060 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 4143 | 0.060 |
Why?
|
| Molecular Mimicry | 1 | 2003 | 72 | 0.060 |
Why?
|
| Anxiety | 1 | 2010 | 1179 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 4053 | 0.050 |
Why?
|
| Cross Reactions | 1 | 2003 | 266 | 0.050 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2002 | 157 | 0.050 |
Why?
|
| Autoantigens | 1 | 2003 | 234 | 0.050 |
Why?
|
| Virion | 1 | 2002 | 161 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2011 | 11965 | 0.050 |
Why?
|
| Herpesviridae Infections | 1 | 2002 | 175 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2006 | 3536 | 0.050 |
Why?
|
| Adoptive Transfer | 1 | 2002 | 446 | 0.040 |
Why?
|
| Exploratory Behavior | 2 | 2010 | 106 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 1491 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2003 | 1681 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2006 | 5637 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 4233 | 0.030 |
Why?
|
| Vaccination | 1 | 2002 | 1123 | 0.030 |
Why?
|
| Humans | 5 | 2017 | 261506 | 0.030 |
Why?
|
| Cell Line | 1 | 2003 | 5114 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 6089 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 7548 | 0.030 |
Why?
|
| Cytokines | 1 | 2003 | 2809 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2010 | 1879 | 0.030 |
Why?
|
| Female | 3 | 2017 | 141928 | 0.030 |
Why?
|
| Dinoprost | 1 | 2010 | 33 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2010 | 47 | 0.020 |
Why?
|
| Adaptation, Ocular | 1 | 2010 | 26 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2010 | 191 | 0.020 |
Why?
|
| Buthionine Sulfoximine | 1 | 2010 | 41 | 0.020 |
Why?
|
| Spin Labels | 1 | 2010 | 76 | 0.020 |
Why?
|
| Cyclic N-Oxides | 1 | 2010 | 106 | 0.020 |
Why?
|
| Physical Conditioning, Animal | 1 | 2010 | 112 | 0.020 |
Why?
|
| Maze Learning | 1 | 2008 | 132 | 0.020 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 215 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2008 | 184 | 0.020 |
Why?
|
| Glutathione | 1 | 2010 | 368 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 443 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 2063 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 3472 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2008 | 1546 | 0.010 |
Why?
|
| Rats | 1 | 2010 | 6086 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2008 | 4804 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2002 | 486 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2002 | 329 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 3254 | 0.010 |
Why?
|
| Adult | 2 | 2003 | 77950 | 0.010 |
Why?
|
| Middle Aged | 2 | 2003 | 86204 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2002 | 2803 | 0.010 |
Why?
|
| Disease Progression | 1 | 2002 | 6682 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2002 | 32848 | 0.000 |
Why?
|